---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-071040"
form_type: "8-K"
ticker: "PTCT"
cik: "0001070081"
company_name: "PTC THERAPEUTICS, INC."
filed_at: "2026-06-05T21:15:21+00:00"
generated_at: "2026-06-05T21:16:15.202055+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# PTC Therapeutics shareholders elect four Class I directors and ratify Ernst & Young

## Summary
- Jessica Chutter, Matthew Klein, Stephanie Okey, and Jerome Zeldis elected Class I directors with >83% of votes cast.
- Ernst & Young LLP ratified as independent auditor for FY 2026 with 76.2M for, 0.4M against.
- Say-on-pay advisory proposal approved with 71.2M for, 1.5M against, 3.9M broker non-votes.
- Annual meeting held June 2, 2026; 82.9M shares outstanding as of April 10, 2026 record date.

## SEC filing metadata
- accession: 0001104659-26-071040
- form_type: 8-K
- ticker: PTCT
- cik: 0001070081
- company_name: PTC THERAPEUTICS, INC.
- filed_at: 2026-06-05T21:15:21+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1070081/000110465926071040/0001104659-26-071040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1070081/000110465926071040/tmb-20260602x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-071040
- JSON: https://secwatch.observer/filing/0001104659-26-071040.json
- Plain text: https://secwatch.observer/filing/0001104659-26-071040.txt

## Key facts
- Shareholder Votes
  PTC THERAPEUTICS, INC. shareholders approved Election of four Class I directors at the 2026-06-02 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-02
  source text: The Company held its Annual Meeting on June 2, 2026 (the “Annual Meeting”). The results for the votes regarding each proposal at the Annual Meeting are set forth below.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1070081/000110465926071040/0001104659-26-071040-index.htm
- Shareholder Votes
  PTC THERAPEUTICS, INC. shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-02 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-02
  source text: The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified by the Company’s stockholders with 76,170,292 votes “For,” 355,794 votes “Against,” and 15,520 votes “Abstained.”
  evidence_url: https://www.sec.gov/Archives/edgar/data/1070081/000110465926071040/0001104659-26-071040-index.htm
- Shareholder Votes
  PTC THERAPEUTICS, INC. shareholders approved Non-binding advisory proposal on named executive officer compensation at the 2026-06-02 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-06-02
  source text: The non-binding advisory proposal on named executive officer compensation was approved by the Company’s stockholders with 71,166,204 votes “For,” 1,492,801 votes “Against,” 24,290 votes “Abstained,” and 3,858,311 broker non-votes.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1070081/000110465926071040/0001104659-26-071040-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.